Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

NVO AGN TEVA ENDP Software Processed Foods CNY Bitcoins 
Benchmark  United States  NYSE  11,016   58.574 Index Moved Up 0.53%  


Processing
Processing. Please wait...

Amarin Probability Of Bankruptcy

   
For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis.The score is used to predict probability of a firm or a fund going into bankruptcy or experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.

Amarin

Probability Of Bankruptcy

=

Normalized

Z-Score

=
93.3 %
Companies or funds with Probability Of Bankruptcy above 90% are generally considered to be high risk with a good chance of bankruptcy in the next 2 years. On the other hand entities with Probability Of Bankruptcy of less than 15% will most likely experience some growth in the next 2 years. Probability Of Bankruptcy is based on Macroaxis own algorithm and can be used by auditors, accountants, money managers, financial advisers, as well as day traders to evaluate unsystematic risk of a stock, fund or ETF.
Compare Amarin to competition

Amarin Probability Of Bankruptcy Assessment

Based on latest financial disclosure Amarin Corporation plc has Probability Of Bankruptcy of 93%. This is 134.3% higher than that of the Healthcare sector, and 60.72% higher than that of Drug Manufacturers - Other industry, The Probability Of Bankruptcy for all stocks is 136.32% lower than the firm.

Filter other Stocks by Probability Of Bankruptcy

Select Probability Of Bankruptcy Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Found 10 equities

Probability Of Bankruptcy

NVO NYQNovo Nordisk AS
1.0%
AGN NYQAllergan Inc
1.0%
TEVA NYQTeva Pharmaceutical Industries Limited
39.33%
ENDP NMSEndo International plc
42.65%
RDY NYQDr Reddys Laboratories Ltd
12.3%
PCYC NMSPharmacyclics Inc
73.09%
TARO NYQTaro Pharmaceutical Industries Ltd
1.0%
UTHR NMSUnited Therapeutics Corporation
2.73%
ISIS NMSIsis Pharmaceuticals Inc
3.37%
LCI NYQLannett Company Inc
1.0%
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Amarin Corporation plc has more than 93 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Fix Your Portfolios with Amarin

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amarin Corporation plc to your portfolio

Amarin Corporation plc Profile

AMRN
Amarin Corporation plc
USA Stock
Currency: USD - US Dollar
Traded on NASDAQ General Markets
 

Other Amarin Fundamentals

Return On Asset(36.84) %
Operating Margin(414.12) %
Current Valuation373.71 M
Shares Outstanding172.88 M
Shares Owned by Insiders3.87 %
Shares Owned by Institutions53.20 %
Number of Shares Shorted26.59 M
Price to Earning291.00 times
Price to Book341.94 times
Price to Sales8.70 times
Revenue34.98 M
Gross Profit14.44 M
EBITDA(143.96 M)
Net Income(130.05 M)
Cash and Equivalents164.28 M
Cash per Share0.95 times
Total Debt245.81 M
Current Ratio6.19 times
Book Value Per Share(0.33) times
Cash Flow from Operations(158.2 M)
Short Ratio17.30 times
One Year High7.4
One Year Low1.28
Earnings Per Share(1.04) times
Price to Earnings To Growth(0.04) times
Number of Employees185
Beta0.8
Market Capitalization293.9 M
Total Asset220.21 M
Retained Earnings(939.85 M)
Working Capital162.78 M
Current Asset194.15 M
Current Liabilities31.36 M
Z Score-5.0
Probability Of Bankruptcy95.20 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities